Literature DB >> 29160309

Structure of PINK1 in complex with its substrate ubiquitin.

Alexander F Schubert1, Christina Gladkova1, Els Pardon2,3, Jane L Wagstaff1, Stefan M V Freund1, Jan Steyaert2,3, Sarah L Maslen1, David Komander1.   

Abstract

Autosomal-recessive juvenile Parkinsonism (AR-JP) is caused by mutations in a number of PARK genes, in particular the genes encoding the E3 ubiquitin ligase Parkin (PARK2, also known as PRKN) and its upstream protein kinase PINK1 (also known as PARK6). PINK1 phosphorylates both ubiquitin and the ubiquitin-like domain of Parkin on structurally protected Ser65 residues, triggering mitophagy. Here we report a crystal structure of a nanobody-stabilized complex containing Pediculus humanus corporis (Ph)PINK1 bound to ubiquitin in the 'C-terminally retracted' (Ub-CR) conformation. The structure reveals many peculiarities of PINK1, including the architecture of the C-terminal region, and reveals how the N lobe of PINK1 binds ubiquitin via a unique insertion. The flexible Ser65 loop in the Ub-CR conformation contacts the activation segment, facilitating placement of Ser65 in a phosphate-accepting position. The structure also explains how autophosphorylation in the N lobe stabilizes structurally and functionally important insertions, and reveals the molecular basis of AR-JP-causing mutations, some of which disrupt ubiquitin binding.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29160309      PMCID: PMC6020998          DOI: 10.1038/nature24645

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  61 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  Studying "invisible" excited protein states in slow exchange with a major state conformation.

Authors:  Pramodh Vallurupalli; Guillaume Bouvignies; Lewis E Kay
Journal:  J Am Chem Soc       Date:  2012-05-03       Impact factor: 15.419

3.  A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1.

Authors:  Nicholas T Hertz; Amandine Berthet; Martin L Sos; Kurt S Thorn; Al L Burlingame; Ken Nakamura; Kevan M Shokat
Journal:  Cell       Date:  2013-08-15       Impact factor: 41.582

Review 4.  PINK1 activation-turning on a promiscuous kinase.

Authors:  Liesbeth Aerts; Bart De Strooper; Vanessa A Morais
Journal:  Biochem Soc Trans       Date:  2015-04       Impact factor: 5.407

5.  Structure of ubiquitin refined at 1.8 A resolution.

Authors:  S Vijay-Kumar; C E Bugg; W J Cook
Journal:  J Mol Biol       Date:  1987-04-05       Impact factor: 5.469

6.  Crystal structure of a LacY-nanobody complex in a periplasmic-open conformation.

Authors:  Xin Jiang; Irina Smirnova; Vladimir Kasho; Jianping Wu; Kunio Hirata; Meng Ke; Els Pardon; Jan Steyaert; Nieng Yan; H Ronald Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-19       Impact factor: 11.205

7.  Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.

Authors:  Ira E Clark; Mark W Dodson; Changan Jiang; Joseph H Cao; Jun R Huh; Jae Hong Seol; Soon Ji Yoo; Bruce A Hay; Ming Guo
Journal:  Nature       Date:  2006-05-03       Impact factor: 49.962

8.  Dali server: conservation mapping in 3D.

Authors:  Liisa Holm; Päivi Rosenström
Journal:  Nucleic Acids Res       Date:  2010-05-10       Impact factor: 16.971

9.  The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition.

Authors:  E D Lowe; M E Noble; V T Skamnaki; N G Oikonomakos; D J Owen; L N Johnson
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

Review 10.  PINK1 and Parkin – mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's disease.

Authors:  Agne Kazlauskaite; Miratul M K Muqit
Journal:  FEBS J       Date:  2014-11-20       Impact factor: 5.542

View more
  32 in total

Review 1.  Building and decoding ubiquitin chains for mitophagy.

Authors:  J Wade Harper; Alban Ordureau; Jin-Mi Heo
Journal:  Nat Rev Mol Cell Biol       Date:  2018-01-23       Impact factor: 94.444

Review 2.  Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond.

Authors:  Andrew N Bayne; Jean-François Trempe
Journal:  Cell Mol Life Sci       Date:  2019-06-28       Impact factor: 9.261

3.  Mitochondria in neurodegeneration.

Authors:  Charleen T Chu
Journal:  Curr Opin Physiol       Date:  2022-04-01

4.  The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization.

Authors:  Byung Hak Ha; Titus J Boggon
Journal:  J Biol Chem       Date:  2017-12-06       Impact factor: 5.157

5.  Quantitative Middle-Down MS Analysis of Parkin-Mediated Ubiquitin Chain Assembly.

Authors:  Kirandeep K Deol; Stephen J Eyles; Eric R Strieter
Journal:  J Am Soc Mass Spectrom       Date:  2020-04-28       Impact factor: 3.109

6.  PINK1 autophosphorylation is required for ubiquitin recognition.

Authors:  Shafqat Rasool; Naoto Soya; Luc Truong; Nathalie Croteau; Gergely L Lukacs; Jean-François Trempe
Journal:  EMBO Rep       Date:  2018-02-23       Impact factor: 8.807

Review 7.  Mitochondrial quality control: from molecule to organelle.

Authors:  Alba Roca-Portoles; Stephen W G Tait
Journal:  Cell Mol Life Sci       Date:  2021-03-29       Impact factor: 9.261

Review 8.  Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance.

Authors:  Ilaria Genovese; Marianna Carinci; Lorenzo Modesti; Gianluca Aguiari; Paolo Pinton; Carlotta Giorgi
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

9.  Mechanism of parkin activation by PINK1.

Authors:  Christina Gladkova; Sarah L Maslen; J Mark Skehel; David Komander
Journal:  Nature       Date:  2018-06-06       Impact factor: 49.962

Review 10.  Regulation of ubiquitin and ubiquitin-like modifiers by phosphorylation.

Authors:  Nathaniel L Hepowit; Carl-Christian Kolbe; Sarah R Zelle; Eicke Latz; Jason A MacGurn
Journal:  FEBS J       Date:  2021-07-21       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.